ADMA BIOLOGICS, INC. (ADMA) Operating margin 2016–2025
ADMA BIOLOGICS, INC. (ADMA) operating margin by fiscal year — reported operating income divided by reported revenue.
37.5%FY2025 · since FY2016: -162.6% → 37.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 37.5% | +4.9 pp |
| FY2024 | 32.6% | +24.2 pp |
| FY2023 | 8.4% | +33.9 pp |
| FY2022 | -25.5% | +46.6 pp |
| FY2021 | -72.1% | +81.6 pp |
| FY2020 | -153.8% | -12.6 pp |
| FY2019 | -141.1% | +213.8 pp |
| FY2018 | -354.9% | -182.2 pp |
| FY2017 | -172.7% | -10.2 pp |
| FY2016 | -162.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice